{"id":"metronidazole-suppositories","safety":{"commonSideEffects":[{"rate":null,"effect":"Vaginal irritation or burning"},{"rate":null,"effect":"Metallic taste (systemic absorption)"},{"rate":null,"effect":"Allergic reactions"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL137","moleculeType":"Small molecule","molecularWeight":"171.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metronidazole is reduced by anaerobic organisms and protozoa to form reactive intermediates that damage DNA and inhibit nucleic acid synthesis, leading to cell death. It is effective against anaerobic bacteria and certain parasites including Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia. The suppository formulation delivers the drug locally to the vaginal or rectal mucosa for topical antimicrobial effect.","oneSentence":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and protozoal DNA by generating reactive oxygen species after reduction of its nitro group.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:59.305Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Vaginal trichomoniasis"},{"name":"Bacterial vaginosis"},{"name":"Anaerobic bacterial infections (rectal/vaginal)"},{"name":"Protozoal infections (Entamoeba, Giardia)"}]},"trialDetails":[{"nctId":"NCT05434104","phase":"NA","title":"The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study","status":"NOT_YET_RECRUITING","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2026-03","conditions":"Bacterial Vaginosis, Candida Vaginal","enrollment":114},{"nctId":"NCT04771728","phase":"PHASE4","title":"A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis","status":"RECRUITING","sponsor":"Peking University Shenzhen Hospital","startDate":"2020-02-01","conditions":"Bacterial Vaginosis","enrollment":140},{"nctId":"NCT06458543","phase":"PHASE4","title":"Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age","status":"RECRUITING","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2024-06-01","conditions":"Bacterial Vaginosis","enrollment":100},{"nctId":"NCT06650540","phase":"NA","title":"Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2024-10-22","conditions":"IVF","enrollment":800},{"nctId":"NCT05783856","phase":"NA","title":"Effects of LiveSpo X-secret in Supporting Treatment of Sexually Transmitted Diseases","status":"COMPLETED","sponsor":"Anabio R&D","startDate":"2020-05-03","conditions":"Sexually Transmitted Diseases","enrollment":100},{"nctId":"NCT03894813","phase":"PHASE4","title":"Probiotics as Adjuvant Treatment for Bacterial Vaginosis","status":"COMPLETED","sponsor":"Peking University Shenzhen Hospital","startDate":"2019-03-26","conditions":"Bacterial Vaginosis","enrollment":126},{"nctId":"NCT03099408","phase":"PHASE4","title":"Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis","status":"COMPLETED","sponsor":"Peking University Shenzhen Hospital","startDate":"2017-07-01","conditions":"Bacterial Vaginosis, Recurrence","enrollment":66},{"nctId":"NCT02942485","phase":"PHASE4","title":"Treatment of Giardia Lamblia Infections in Children","status":"TERMINATED","sponsor":"Helsinki University Central Hospital","startDate":"2016-12-01","conditions":"GIARDIASIS","enrollment":8},{"nctId":"NCT04035785","phase":"PHASE4","title":"A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)","status":"UNKNOWN","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2019-07-28","conditions":"Pelvic Inflammatory Diseases","enrollment":240},{"nctId":"NCT03446443","phase":"PHASE4","title":"Honghe Fujie Lotion for the Treatment of Bacterial Vaginosis","status":"UNKNOWN","sponsor":"Dongfang Hospital Beijing University of Chinese Medicine","startDate":"2018-07-26","conditions":"Bacterial Vaginitis","enrollment":240},{"nctId":"NCT01361048","phase":"PHASE2","title":"Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2011-12","conditions":"Trichomonas Vaginitis","enrollment":40},{"nctId":"NCT02185456","phase":"EARLY_PHASE1","title":"Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis","status":"UNKNOWN","sponsor":"Wayne State University","startDate":"2014-09","conditions":"Bacterial Vaginosis","enrollment":200},{"nctId":"NCT01230814","phase":"PHASE2","title":"Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-04","conditions":"Bacterial Vaginosis, Candidiasis, Trichomoniasis","enrollment":234},{"nctId":"NCT01937650","phase":"PHASE2, PHASE3","title":"Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda","status":"COMPLETED","sponsor":"Makerere University","startDate":"2009-06","conditions":"Cervix Carcinoma","enrollment":38}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":20,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Metronidazole Suppositories","genericName":"Metronidazole Suppositories","companyName":"Dongfang Hospital Beijing University of Chinese Medicine","companyId":"dongfang-hospital-beijing-university-of-chinese-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and protozoal DNA by generating reactive oxygen species after reduction of its nitro group. Used for Anaerobic bacterial infections of the colon and rectum, Protozoal infections (e.g., trichomoniasis, amebiasis), Bacterial vaginosis (local treatment).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}